drugset / Trial / NCT00024050

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome

NCT00024050

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy. PURPOSE: Phase II trial to study the effectiveness of chemotherapy followed by peripheral stem cell transplantation in treating patients who have myelodysplastic syndrome.

Timeline

Start
2001-02
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Busulfan Small molecule Oral
Subject Cyclophosphamide Other / unclassified Intravenous
Subject Cyclosporine Peptide Intravenous
Subject Methotrexate Small molecule Intravenous